Literature DB >> 8208962

Differentiation of adrenal masses with MR imaging: comparison of techniques.

J W Reinig1, J E Stutley, C M Leonhardt, K M Spicer, M Margolis, C B Caldwell.   

Abstract

PURPOSE: To determine the efficacy of various magnetic resonance (MR) imaging sequences for the differentiation of adrenal masses.
MATERIALS AND METHODS: Fifty-three adrenal masses in 46 patients (adenomas, metastases, myelolipomas, hemorrhages, and pheochromocytomas) were evaluated by means of T1-, T2-, and T2*-weighted sequences, calculated T2 values, chemical shift imaging techniques, and dynamic contrast material-enhanced imaging. The Student t test and receiver operating characteristic analysis were used to evaluate the differences in the groups of masses.
RESULTS: Analysis of the chemical shift-induced signal intensity of the adrenal masses and the T2*-weighted sequence enabled differentiation of adenomas, metastases, and pheochromocytomas. Adenomas and pheochromocytomas were also differentiated by means of a heavily T2-weighted sequence. Signal intensity values for all masses overlapped.
CONCLUSION: Although a chemical shift imaging technique and a T2*-weighted sequence helped correctly differentiate among the groups of adrenal masses, the degree of overlap suggests that it is still difficult to evaluate disease in individual patients.

Entities:  

Mesh:

Year:  1994        PMID: 8208962     DOI: 10.1148/radiology.192.1.8208962

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  10 in total

1.  Magnetic resonance imaging differentiation of adrenal masses at 1.5 T: T2-weighted images, chemical shift imaging, and Gd-DTPA dynamic studies.

Authors:  R Z Słapa; W Jakubowski; E Dabrowska; A Januszewicz; B Tymińska; T Feltynowski; M Lapiński; J Fijuth
Journal:  MAGMA       Date:  1996 Sep-Dec       Impact factor: 2.310

Review 2.  Noninvasive adrenal imaging in hyperaldosteronism.

Authors:  Daniel R Simon; Michael A Palese
Journal:  Curr Urol Rep       Date:  2008-01       Impact factor: 3.092

Review 3.  The clinical evaluation of silent adrenal masses.

Authors:  B Ambrosi; E Passini; T Re; L Barbetta
Journal:  J Endocrinol Invest       Date:  1997-02       Impact factor: 4.256

4.  Scintigraphy of incidentally discovered bilateral adrenal masses.

Authors:  M D Gross; B Shapiro; I R Francis; R L Bree; M Korobkin; M K McLeod; N W Thompson; J A Sanfield
Journal:  Eur J Nucl Med       Date:  1995-04

Review 5.  Metabolic and anatomic characteristics of benign and malignant adrenal masses on positron emission tomography/computed tomography: a review of literature.

Authors:  Asha Kandathil; Ka Kit Wong; Daniel J Wale; Maria Chiara Zatelli; Anna Margherita Maffione; Milton D Gross; Domenico Rubello
Journal:  Endocrine       Date:  2014-10-02       Impact factor: 3.633

Review 6.  Factors influencing adrenal metastasis in renal cell carcinoma.

Authors:  S M Moudouni; I En-nia; A Manunta; F Guillé; B Lobel
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

7.  Primary hepatic pheochromocytoma.

Authors:  A Rimmelin; M Hartheiser; A Gangi; M Welsch; M Y Jeung; D Jaeck; J Tongio; J L Dietemann
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

8.  Macronodular congenital adrenal hyperplasia in an adult with female pseudohermaphroditism.

Authors:  A M Norris; J B O'Driscoll; H Mamtora
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

9.  Imaging of lung cancer: Implications on staging and management.

Authors:  Nilendu C Purandare; Venkatesh Rangarajan
Journal:  Indian J Radiol Imaging       Date:  2015 Apr-Jun

10.  Adrenal collision tumors and their mimics: multimodality imaging findings.

Authors:  Venkata S Katabathina; Erin Flaherty; Ravi Kaza; Vijayanadh Ojili; Kedar N Chintapalli; Srinivasa R Prasad
Journal:  Cancer Imaging       Date:  2013-12-30       Impact factor: 3.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.